Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015· article· en· New England Journal of Medicine· Medicine
aff
12 000
citations
Travaux
Tous les travaux de la base. Chaque rangée indique les voies par lesquelles le travail a été admis, car une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée.
Voie
Domaine
Type
Langue
Période
à
Consensus du tri
Ordre
Indicateurs
Données de dépistage
Les étiquettes directes sont rares et non validées. Une absence reste inconnue.
1 filtre actif
10 000+ travauxpage 1
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2004· article· en· The Lancet· Medicine
aff
11 970
citations
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
2017· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
aff
9 109
citations
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010· article· en· Journal of the American Society of Echocardiography· Medicine
affaboutsans résumé
7 013
citations
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008· article· en· New England Journal of Medicine· Medicine
aff
6 637
citations
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
2001· article· en· New England Journal of Medicine· Medicine
aff
6 486
citations
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018· article· en· New England Journal of Medicine· Medicine
aff
6 310
citations
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
2017· article· en· New England Journal of Medicine· Medicine
afffund
5 539
citations
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013· review· en· The Lancet· Medicine
affsans résumé
4 971
citations
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004· article· en· New England Journal of Medicine· Medicine
aff
4 942
citations
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
2007· article· en· New England Journal of Medicine· Medicine
aboutno aff
4 694
citations
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
2015· article· en· New England Journal of Medicine· Medicine
aff
4 415
citations
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
2009· article· en· Obstetrical & Gynecological Survey· Medicine
aff
3 658
citations
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
2018· article· en· New England Journal of Medicine· Medicine
aff
3 519
citations
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013· article· en· New England Journal of Medicine· Medicine
aff
3 474
citations
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007· article· en· New England Journal of Medicine· Medicine
aff
3 144
citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019· article· en· The Lancet· Medicine
affsans résumé
3 040
citations
The Metabolic Syndrome and Cardiovascular Risk
2010· review· en· Journal of the American College of Cardiology· Medicine
afffundsans résumé
2 998
citations
Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
2010· article· en· New England Journal of Medicine· Medicine
aff
2 988
citations
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
2003· article· en· The Lancet· Medicine
affsans résumé
2 984
citations
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
2019· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
afffundabout
2 967
citations
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
2005· article· en· The Lancet· Medicine
afffundsans résumé
2 897
citations
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018· review· en· The Lancet· Medicine
affsans résumé
2 818
citations
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001· article· en· The Lancet· Medicine
affsans résumé
2 808
citations
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015· article· en· New England Journal of Medicine· Medicine
aff
2 590
citations